2019, Number 4
<< Back Next >>
Rev cubana med 2019; 58 (4)
Behçet syndrome complicated with deep vein thrombosis in lower limbs
Suárez IR, Chirino DL
Language: Spanish
References: 8
Page: 1-9
PDF size: 261.37 Kb.
ABSTRACT
This paper reports a 32-year-old male patient who was hospitalized for weight loss, decay,
cloudy urine and pain in the right inguinal region. The clinical evolution, imaging and
laboratory studies allowed diagnosing Behçet Syndrome. The patient showed main signs as
recurrent mouth ulcerations, anterior uveitis and deep vein thrombosis in the lower limbs.
The clinical condition of this patient and the joint assessment of various medical specialties
were the key factors in establishing the definitive diagnosis. The patient´s evolution was
satisfactory treated with prednisone and anticoagulants.
REFERENCES
Kasper DL, Jameson JL, Anthony SF, Longo DL, Loscalzo J. Principios de Medicina Interna. Volumen II. Parte 15. Sección 2.19a edición. Editorial Mc Graw Hill Education. Impreso en China. 2016.p 2194.
Thomas T, Chandan J, Subramanian A, Gokhale K, Gkoutos G, Harper L, et al. Epidemiology, morbidity and mortality in Behçet's disease: a cohort study using The Health Improvement Network (THIN). Rheumatology. 2020. [acceso: 20/02/2020]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/32040196
Rozman C, Cardellach LF. Medicina Interna. XVIII edición. Volumen I. Sección VII. Reumatología y enfermedades sistémicas. Capítulo 108. Editorial ELSEVIER. Barcelona, España. 2016. p 1058-59.
Colectivo de autores. Capítulo 147.Vasculitis sistémicas. Síndrome de Behçet. En: Noya Chaveco ME, Moya Gonzalez NL. Roca Goderich. Temas de Medicina Interna. Tomo III. 5ta edición. La Habana: Editorial Ecimed; 2017.p 94-97.
Wallace GR. HLA-B*51 the primary risk in Behçet disease. Proc Natl Acad Sci USA. 2014;111(24):8706-07. https://doi.org/10.1073/pnas.1407307111
Tutar B, Kantarci F, Cakmak OS, Yazici H, Seyahi E. Assessment of deep venous thrombosis in the lower extremity in Behçet's syndrome: MR venography versus Doppler ultrasonography. Intern Emerg Med. 2019[acceso: 29/01/2020];14(5):705-711. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/30712149
Toledo Samaniego N, Galeano Valle F, Ascanio Palomares P, González Martínez B, Valencia Kruszyna A, Demelo Rodríguez P. Neurological manifestations of Behçet's disease: Study of 57 patients. Med Clin (Barc). 2020[acceso: 24/02/2020]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/31924326
Ombrelloa MJ, Kirinob Y, de Bakkered PIW, Gulh A, Kastnerb DL, Remmers EF. Behçet disease-associated MHC class I residues implicate antigen binding and regulation of cellmediated cytotoxicity. PNAS. 2014;111(24):8867-72. https://doi.org/10.1073/pnas.1406575111